Greenbrier & Russel launches Patient Intelligence Registry

Twitter icon
Facebook icon
LinkedIn icon
e-mail icon
Google icon

Greenbrier & Russel, a business and technology services firm, unveiled an information framework called Patient Intelligence Registry at HIMSS 2006 last week in San Diego. The tool is built to systemize clinical, business and operational data for healthcare organizations.

Patient Intelligence Registry will support programs such as disease management, outcomes management, clinical performance and process improvement, cost and waste reduction, quality accreditation, predictive analytics, and provide data for healthcare research.

"Patient registries have a long history in a wide variety of healthcare and health-related organizations, but have been overlooked for their potential value," said Scott Wanless, leader, business intelligence healthcare unit, Greenbrier & Russel.  "This is especially critical in times of rapidly rising healthcare costs, increased demand for information by those paying for healthcare services, as well as increasing demand for data to support quality, safety and compliance needs," Wanless said.

The Patient Intelligence Registry includes three key components:

  • Patient Intelligence Registry TM Source Systems — extracts data from a client's operational applications, such as hospital and/or clinic management data, lab data, pharmacy data, claims data, administrative data, etc;
  • Patient Intelligence Registry Data Repository Systems — takes the data extracts using industry standard Extract/Transformation/Load (ETL) processes and cleans, organizes and prepares the data for loading into a historical repository (or data warehouse);
  • Patient Intelligence Registry Data Marts and Analytical Reporting Systems — selects data for specific reporting and analytical subject areas, summarizes the data based on business requirements, and provides data access for analysis and decision-making purposes.

The business driver of a Patient Intelligence Registry is the increasing number and scope of clinical oversight organizations (patient safety, efficiency, affordability), as well as the demand for information from healthcare buyers and other advocacy groups, said Wanless.

He added that “healthcare management has been clamoring for 'clinical-style' evidence to support product and service-line decisions, location and access decisions, support quality accreditation and marketing efforts. The bottom line is greater efficiency, reduced waste, better staffing and revenue prediction."